- Issuer ticker
-
ELAN
- Reported as of
-
01 Apr 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
07 Apr 2026, 16:30:20 UTC
Filing notes and source
Key filing fact
Ellen de Brabander filed Form 4 for Elanco Animal Health Inc (ELAN) on 07 Apr 2026.
Key facts
- This page summarizes Ellen de Brabander's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Apr 2026, 16:30.
Change
- Previous filing in this sequence was filed on 12 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001892179
Primary reporting owner
de Brabander Ellen
- Relationship
-
Executive Vice President, Research, Development and Regulatory Affairs
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- Shares
- +40,985
- Change %
- +16%
- Price
-
$0.000000*
- Shares after
- 301,109
- Date
- 01 Apr 2026
- Ownership
- Direct
ELAN
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -20,288
- Change %
- -6.7%
- Price
-
$23.12*
- Shares after
- 280,821
- Date
- 01 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
SEC remarks
Executive Vice President, Research, Development and Regulatory Affairs